HomeNewsEstonia to introduce the future vision of personal...
Estonia to introduce the future vision of personalized medicine at Cannes Lions Health
Aaviksoo: “The health care of the future will be preventive, personalized and patient inclusive.”
Ain Aaviksoo, Deputy Secretary General for E-services and Innovation at the Ministry of Social Affairs, has been confirmed as a presenter at the Cannes Lions Health conference, to be held on 18 and 19 June. Aaviksoo will speak to an audience of international experts about the personalized health system supported with digital solutions.
“In the light of continuous development of technology, personalized medicine is a tangible future where the health and gene information of a person allows the provision of patient-friendly health services both for prevention and, if necessary, for treatment,” says Aaviksoo. “The health care of the future will be preventive, personalized and patient inclusive.”
According to Aaviksoo, Estonia’s advantage is its technological capability to test new solutions in a secure way. “With X-road we already have an infrastructure that allows secure sharing and using of data stored about people in various sources, including the data in the gene bank. Moreover, people are very ready to enjoy novel and convenient services by combining available data. When we bring all these different conditions together, it is possible to create solutions that help people maintain their health, monitor and prevent problems,” says Aaviksoo.
Ain Aaviksoo will present a vision about a fully personalized health system supported by digital solutions at the Cannes Lions Health Conference. Part of the presentation will be a demonstration of DNA-testing, instructed by the Communication Manager of the Estonian Genome Center, Ms Annely Allik.
In Estonia, the national programme for developing personalized medicine and its application in health care in Estonia for 2016–2020 is being prepared with a view to developing personalized medicine.
Estonia has started a program to recruit and genotype 100,000 new biobank participants as part of its National Personalized Medicine programme. Effort aims to develop personalized medicine in national healthcare.
The Estonian Government will allocate 5 million euros next year to a joint development project of the Ministry of Social Affairs, the National Institute for Health Development and the Estonian Genome Center of the University of Tartu. The project aims to collect the genetic data of 100 000 people and integrate it into everyday medical practice by giving people feedback of their personal genetic risks. The general purpose of the project is to boost the development of personalised medicine in Estonia.